severe combined immunodeficiency
Showing 1 - 25 of 28
Genetic Basis of Immunodeficiency
Recruiting
- Severe Combined Immunodeficiency
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
The Experience of Screening for SCID
Recruiting
- Severe Combined Immunodeficiency
- SCID Screening
-
London, United KingdomKing's College London
Dec 6, 2022
Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant
Recruiting
- Immune Deficiency Disorders
- +13 more
- Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
-
Saint Louis, MissouriWashington University
Apr 25, 2022
Haematological Malignancy, Acute Leukemia, MDS Trial in Lyon (Physical activity program)
Not yet recruiting
- Haematological Malignancy
- +5 more
- Physical activity program
-
Lyon, FranceInstitut d'Hématologie et d'Oncologie Pédiatrique
Mar 25, 2022
Haematological Malignancy, Acute Leukemia, MDS Trial in Lyon (Physical activity program)
Withdrawn
- Haematological Malignancy
- +5 more
- Physical activity program
-
Lyon, FranceInstitut d'Hématologie et d'Oncologie Pédiatrique
Feb 10, 2022
Severe Combined Immunodeficiency Trial in San Francisco (AProArt, CliniMACS® CD34 Reagent System cell sorter device, Busulfan)
Recruiting
- Severe Combined Immunodeficiency
- AProArt
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco (UCSF) Children's Hospit
Feb 4, 2022
Neonatal Screening of Severe Combined Immunodeficiencies
Completed
- Severe Combined Immunodeficiency
- Neonatal Screening
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Jan 3, 2022
Patients Who Have Received Gene Therapy Or Gene Marked Products
Recruiting
- Severe Combined Immunodeficiency
- +4 more
- Venipuncture
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Dec 10, 2021
Severe Combined Immunodeficiency Trial in Memphis (drug, device, other)
Recruiting
- Severe Combined Immunodeficiency
- Anti-thymocyte globulin (rabbit)
- +5 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 6, 2021
Through Imaging of Visceral Lymphoid Organs in SCID Who Have
Completed
- Severe Combined Immunodeficiency
-
Paris, FranceHôpital Necker
Jul 21, 2021
Bone Marrow Failure Syndrome, Thalassemia, Sickle Cell Disease Trial in Gainesville (Thiotepa--single daily dose,
Recruiting
- Bone Marrow Failure Syndrome
- +15 more
- Thiotepa--single daily dose
- Thiotepa--escalated dose
-
Gainesville, FloridaUF Health Shands Children's Hospital
Jul 8, 2021
Severe Combined Immunodeficiency Trial in Los Angeles (ADA gene transfer)
Completed
- Severe Combined Immunodeficiency
- ADA gene transfer
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Apr 21, 2021
Severe Combined Immunodeficiency Trial in Jerusalem, Petach Tikva (TBX-1400)
Not yet recruiting
- Severe Combined Immunodeficiency
- TBX-1400
-
Jerusalem, Israel
- +1 more
Oct 6, 2020
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +77 more
- fludarabine phosphate
- +8 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 16, 2019
Adenosine Deaminase Deficiency, Autosomal Recessive Disorder, Immune System Disorder Trial in Seattle (procedure, drug, other,
Completed
- Adenosine Deaminase Deficiency
- +6 more
- Allogeneic Bone Marrow Transplantation
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 26, 2019
Severe Combined Immunodeficiency Trial in San Francisco (Transplant Conditioning with Mobilization Only, Transplant Conditioning
Terminated
- Severe Combined Immunodeficiency
- Transplant Conditioning with Mobilization Only
- Transplant Conditioning with Mobilization and Alemtuzumab
-
San Francisco, CaliforniaUCSF Benioff Children's Hospital
Jul 4, 2018
Severe Combined Immunodeficiency Trial in Los Angeles (unrelated BM with T cell depletion, unrelated cord blood, haplo BM with T
Terminated
- Severe Combined Immunodeficiency
- unrelated BM with T cell depletion
- +3 more
-
Los Angeles, CaliforniaChildren's Hospital Los Angeles
Aug 18, 2017
Severe Combined Immunodeficiency Trial run by the NIAID (Gene-Transduced Autologous CD34+ Stem Cells)
Completed
- Severe Combined Immunodeficiency
- Gene-Transduced Autologous CD34+ Stem Cells
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
s on Female Adolescents' Decisions Regarding Testing for Carrier
Completed
- Severe Combined Immunodeficiency
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Anemia, Aplastic, Fanconi Anemia, Hematologic Diseases Trial (stem cell transplantation)
Completed
- Anemia, Aplastic
- +7 more
- stem cell transplantation
- (no location specified)
Apr 12, 2016
Severe Combined Immunodeficiency Trial in Shanghai (gene sequencing)
Unknown status
- Severe Combined Immunodeficiency
- gene sequencing
-
Shanghai, Shanghai, ChinaShanghai children's medical center
Sep 1, 2014
Bone Marrow Failure, Osteopetrosis, Fanconi Anemia Trial in New York (Fludarabine, Cyclophosphamide, Cyclophosphamide 40)
Unknown status
- Bone Marrow Failure
- +3 more
- Fludarabine
- +3 more
-
New York, New YorkColumbia University Medical Center
Oct 18, 2011
Immunologic Deficiency Syndromes, Chediak-Higashi Syndrome, Common Variable Immunodeficiency Trial in Minneapolis
Terminated
- Immunologic Deficiency Syndromes
- +13 more
- anti-thymocyte globulin
- +8 more
-
Minneapolis, MinnesotaFairview University Medical Center
Oct 14, 2009
Immunologic Deficiency Syndrome, Agammaglobulinemia, Severe Combined Immunodeficiency Trial in Canada, United States (Immune
Completed
- Immunologic Deficiency Syndrome
- +4 more
- Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified
- Dextrose, 5% in Water
-
Birmingham, Alabama
- +12 more
Sep 24, 2009